Edition:
United States

Diffusion Pharmaceuticals Inc (DFFN.OQ)

DFFN.OQ on NASDAQ Stock Exchange Capital Market

0.46USD
20 Jul 2018
Change (% chg)

$0.01 (+3.09%)
Prev Close
$0.45
Open
$0.44
Day's High
$0.47
Day's Low
$0.44
Volume
12,602
Avg. Vol
38,523
52-wk High
$3.02
52-wk Low
$0.44

Chart for

About

Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The Company's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC)... (more)

Overall

Beta: -1.26
Market Cap(Mil.): $23.63
Shares Outstanding(Mil.): 50.53
Dividend: --
Yield (%): --

Financials

  DFFN.OQ Industry Sector
P/E (TTM): 0.38 214.53 33.05
EPS (TTM): 1.17 -- --
ROI: 273.97 -3.67 13.17
ROE: 56.53 -5.61 15.10

BRIEF-Diffusion Pharmaceuticals Files Prospectus Related To Offering Of Common Stock

* DIFFUSION PHARMACEUTICALS INC FILES PROSPECTUS RELATED TO OFFERING UP TO 12.3 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING‍​ Source text: (http://bit.ly/2nGHE9Q) Further company coverage:

Feb 06 2018

Earnings vs. Estimates